Microtubule transport of herpesvirus capsids from the cell periphery to the nucleus is imperative for viral replication and, in the case of many alphaherpesviruses, transmission into the nervous system. Using the neuroinvasive herpesvirus, pseudorabies virus (PRV), we show that the viral protein 1/2 (VP1/2) tegument protein associates with the dynein/dynactin microtubule motor complex and promotes retrograde microtubule transport of PRV capsids. Functional activation of VP1/2 requires binding to the capsid protein pUL25 or removal of the capsid-binding domain. A proline-rich sequence within VP1/2 is required for the efficient interaction with the dynein/ dynactin microtubule motor complex as well as for PRV virulence and retrograde axon transport in vivo. Additionally, in the absence of infection, functionally active VP1/2 is sufficient to move large surrogate cargoes via the dynein/dynactin microtubule motor complex. Thus, VP1/2 tethers PRV capsids to dynein/dynactin to enhance microtubule transport, neuroinvasion, and pathogenesis.
INTRODUCTION
Upon entering a host cell, many viruses move centripetally along microtubules to reach sites of replication. Although the dynein/ dynactin motor complex is implicated in the transport of viruses at this early step of infection, molecular events underlying viral recruitment of dynein/dynactin remain poorly defined (reviewed in Dodding and Way, 2011) . Understanding the biology of dynein-based transport is particularly important for the study of neuroinvasive herpesviruses such as herpes simplex virus (HSV) and varicella zoster virus. While the high incidence of neuroinvasive herpesvirus infections is primarily attributed to the propensity of these agents to establish latent infections, latency establishment is contingent on retrograde axon transport to neuronal soma, a process dependent upon dynein/dynactin recruitment to the herpesvirus capsid.
Pseudorabies virus (PRV) is a veterinary herpesvirus noted for its pronounced neuroinvasion and virulence in many mammalian hosts (Enquist, 1994) . Like other neuroinvasive herpesviruses, PRV transports on axonal microtubules to deliver its genetic information to neurons in sensory ganglia (retrograde transport) and later to reemerge from the nervous system by spreading to innervated peripheral tissues (anterograde transport) (Bosem et al., 1990; Kristensson et al., 1986; Openshaw et al., 1978) . Herpesviruses consist of an enveloped icosahedral capsid that contains tegument proteins between the capsid and envelope. Upon entering neurons, the outer components of the PRV virion, including the envelope and a subset of tegument proteins, are shed . The remaining capsid-tegument entry complex participates in rapid microtubule-dependent retrograde transport (Antinone and Smith, 2010; . Evidence is accumulating that several proteins of the entry complex are effectors for early events leading up to the injection of the viral genome into the nucleus (Delboy and Nicola, 2011; Douglas et al., 2004; Krautwald et al., 2009; Rode et al., 2011) . However, as is the case for most viruses, the specific viral proteins that engage the dynein/dynactin motor complex and enable minusend-directed microtubule transport remain undefined.
Viral protein 1/2 (VP1/2; also called pUL36) is a large tegument protein bound directly to the capsid surface and a component of the capsid-tegument entry complex (Antinone and Smith, 2010; Cardone et al., 2012; . PRV deleted for the gene encoding VP1/2 fails to propagate, making functional studies of VP1/2 during early infection difficult (Fuchs et al., 2004; . Nevertheless, several studies have documented that VP1/2 is critical for delivery of incoming viral particles to nuclear pores and release of the viral DNA into the nucleus (Abaitua et al., 2012; Jovasevic et al., 2008; Roberts et al., 2009; Schipke et al., 2012) . In this study we demonstrate that VP1/2 associates with the dynein motor and is a potent effector of microtubule-dependent transport that can function independently of other viral proteins to move cargo in cells. VP1/2 was expressed in an inert state in the absence of other viral proteins, but was activated either by coexpression with its binding partner, pUL25, or by removal of the pUL25 binding site in the VP1/2 C terminus. Additionally, several regions of VP1/2 contributed to binding of dynactin, a cellular complex that augments dynein-based microtubule transport. In particular, deletion of a large proline-rich sequence in VP1/2 reduced dynactin binding, axon transport in culture, and neuroinvasion in vivo. Based on these findings, we infer that VP1/2 is active when bound to the capsid surface where it recruits dynein/dynactin and promotes the sustained retrograde microtubule transport necessary to travel long distances in axons and invade the nervous system.
RESULTS

The C-Terminal Capsid-Binding Domain in VP1/2 Modulates Cellular Localization and Intracellular Transport
VP1/2 is a capsid-bound tegument protein and is the largest protein encoded by the herpesviridae (Gibson and Roizman, 1972) . Approximately one-third of VP1/2 consists of proline-rich sequences that map to two regions of the protein ( Figure 1A ). Although the two proline-rich regions of VP1/2 ortho-logs of other alphaherpesviruses are positionally maintained, the primary sequences of the proline-rich regions are divergent between viruses. When transiently expressed in the absence of other viral proteins, a PRV RFP-VP1/2 fusion protein was diffusely distributed and was often nuclear enriched ( Figure 1B ). This distribution of VP1/2 is consistent with previous reports of transiently expressed HSV and PRV VP1/2 (Abaitua and O'Hare, 2008; . During infection VP1/2 interacts with capsids through multiple points of contact with the capsid surface (Cardone et al., 2012) . One domain of VP1/2 that contributes to the capsid interaction has been mapped to the 62 C-terminal amino acids, which are sufficient for capsid binding through an interaction with the pUL25 capsid protein Pasdeloup et al., 2009 ). Similar to VP1/2, a GFP-pUL25 fusion protein was diffusely distributed when transiently expressed, consistent with previous reports of HSV pUL25 (Ogasawara et al., 2001; Rode et al., 2011) . In contrast, coexpression of RFP-VP1/2 and GFP-pUL25 resulted in redistribution of both proteins to the nuclear membrane and perinuclear region ( Figure 1C ). The intensity of nuclear rim localization was variable but was clearly evident in 28% (n = 97) of transfected cells; perinuclear localization was less frequent. The observed redistribution to the nuclear rim was often accompanied by a punctate pattern of fluorescence from the cytoplasm, which was subsequently determined to be motile (see below).
Capsid-VP1/2 complexes translocate to the nucleus upon entering cells (Antinone and Smith, 2010; Copeland et al., 2009; Jovasevic et al., 2008; Morrison et al., 1998; Schipke et al., 2012) . Therefore, the nuclear membrane localization of coexpressed VP1/2 and pUL25 was noteworthy. The mechanism underlying VP1/2-pUL25 redistribution could be intrinsic to either protein; however, we have previously noted that VP1/2 can localize to the nuclear membrane during PRV infection . Consistent with these observations, removal of the C-terminal pUL25 binding site from VP1/2 (VP1/2 R7) enhanced nuclear rim localization greater than 10-fold in the absence of pUL25, indicating that nuclear rim localization was an intrinsic property of VP1/2 ( Figure 1D ). These results predict that VP1/2 is kept inactive by the carboxyl tail, possibly by changes in confirmation or destabilization, when not bound to capsids via pUL25.
In addition to nuclear rim localization, 9% of cells transiently expressing GFP-VP1/2 R7 (n = 548) displayed remarkable cytoplasmic transport of diffraction-limited fluorescent punctae ( Figure 2A ; Movie S1). GFP-VP1/2 R7 punctae moved along curvilinear trajectories at average velocities of 1.15 mm/s (SD = 0.02; n > 600 runs) ( Figure S1A ). This movement was sensitive to the microtubule depolymerizing agent nocodazole but not to the actin depolymerizing agent cytochalasin D ( Figure S1B ). As with the observed nuclear rim localization of GFP-VP1/2 R7, microtubule-dependent transport was reminiscent of events that capsids undergo upon entering cells (Sodeik et al., 1997) .
To determine if motility occurred by a mechanism that was capable of moving large cargoes through the cytosol, GFP-VP1/2 R7 was fused to a membrane targeting sequence (MTS) that anchors proteins to the exterior of mitochondria Pistor et al., 1994) . The N terminus of the Bicaudal D protein (BICD-N), which binds dynein/dynactin, redistributes mitochondria to the microtubule-organizing center (MTOC) when fused to a MTS . For the following experiments, a GFP-BICD-N-MTS fusion served as a positive control for redistribution of mitochondria to the MTOC, and a GFP-MTS was the negative control. Each MTS-tagged protein colocalized with mitochondria in transfected cells ( Figure 2B ). GFP-VP1/2 R7-MTS induced perinuclear clustering of mitochondria in 37% of transfected cells, which was greater than the negative control (10%, p = 0.00014), although not as effective as the BICD-N construct (76%, p < 0.00001) ( Figures 2B and 2C) . A pUL25-GFP-MTS fusion protein redistributed mitochondria only in the presence of full-length VP1/2, confirming that VP1/2 and pUL25 formed a complex that induced cargo transport ( Figures 2B and 2C ). Full-length VP1/2 lacking a MTS tag did not redistribute mitochondria, indicating that VP1/2 expression did not affect mitochondrial localization indirectly ( Figure 2C ). In all cases perinuclear clustering of mitochondria was nocodazole sensitive (Figures S1C-S1E). These experiments document the capacity of VP1/2 to move cargo under load by a microtubule-dependent transport process in intact cells and further demonstrate that this property was masked in the full-length VP1/2 protein in the absence of its capsid-binding partner, pUL25.
VP1/2 Interacts with the Dynein/Dynactin Motor Complex
The ability of VP1/2 to move on microtubules and redistribute mitochondria to the perinuclear region of cells led us to examine whether VP1/2 could interact with components of the minus-end-directed ]dynein/dynactin microtubule motor complex. To test this possibility, GFP-VP1/2 was immunoprecipitated from transiently transfected HEK293 cells and probed for the presence of the dynein intermediate chain and the p150/glued dynactin subunit. Unexpectedly, full-length VP1/2 coimmunoprecipitated both dynein/dynactin components despite it likely being in an inactive conformation ( Figure 3B ). Because the interaction with p150/glued proved robust, it was used to examine the VP1/ 2-dynein/ dynactin interaction in more detail. GFP-VP1/2 lacking region 7 coimmunoprecipitated dynactin at 79% ± 49% (mean ± SD; n = 3) of the efficiency of full-length GFP-VP1/2 ( Figure 3C ). Because VP1/2 R7 actively engaged in microtubule-dependent transport, it was used to identify additional regions required for binding dynactin proteins by introducing a series of in-frame deletions ( Figure 3A) . Individual in-frame deletions of regions 1-5 did not diminish the interaction between VP1/2 R7 and dynactin components p150/glued and p50/dynamitin ( Figure 3D ). In contrast, a GFP-VP1/2 R6 R7 truncation was severely compromised for binding, as was a variant of GFP-VP1/2 R7 deleted for a subregion of region 6, referred to here as R6 S (aa 2080-2796) ( Figure 3E ). The R6 S allele was based on a previously described in-frame deletion that attenuated, but did not prevent, PRV propagation (Böttcher et al., 2006) . Because expression of GFP-VP1/ 2 R6 R7 and GFP-VP1/2 R6 S R7 was restricted to the nucleus, variants of these isoforms lacking an endogenous nuclear localization sequence were also examined to rule out that nuclear targeting contributed to the reduction of p150/ glued and p50/dynamitin binding (Figures 3E and S2A) (Abaitua and O'Hare, 2008) .
Although VP1/2 regions 1-4 in the GFP-VP1/2 R7 construct were individually dispensable for the interaction with dynactin proteins, a single deletion of regions 1-4 resulted in a 5-fold (p150/ glued) and 9-fold (p50/dynamitin) decrease in binding when the C terminus was intact ( Figure 3F ). Deletion of regions 1-5 only incrementally reduced binding in comparison to deletion of regions 1-4: 8-fold (p150/glued) and 11-fold (p50/dynamitin). While additional studies will be required to understand the full extent of the VP1/2-dynactin interaction, the C-terminal third of VP1/2 (consisting of regions 6 and 7) was the smallest fragment identified that was sufficient for the dynactin interaction ( Figure 3F ). The minimal VP1/2 regions 6 and 7 construct also cosedimented with endogenous dynein/dynactin from transiently ]overexpressing cells (Figures S2B and S2C) . While this latter approach did not conclusively document an interaction with the 20S dynein motor, the findings supported those obtained by coimmunoprecipitation and the motility observed in transfected cells.
When the region 6 S deletion was combined with deletion of regions 1-4, binding to dynactin was nearly eliminated (19-fold decrease in p150/glued binding and 23-fold decrease in p50/ dynamitin binding). In the context of full-length VP1/2, deletion of region 6 S significantly decreased binding to p150/glued (5-fold decrease, p = 0.00015) and p50/dynamitin (4-fold decrease, p = 0.0005) ( Figure 3F ). These findings indicated that region 6 S along with sequences within regions 1-4 contributed to binding individual protein components of dynactin. Collectively, results from coimmunoprecipitation and cosedimentation were consistent with a functional VP1/2-dynein/ dynactin interaction and with the robust microtubule-based motility observed in living cells. Regions 2-7 cannot be individually deleted from VP1/2 without ablating PRV propagation; however, PRV lacking region 6 S is viable (Böttcher et al., 2006; . Therefore, the effect of deleting region 6 S on the cytoplasmic transport of PRV capsids during infection was next examined.
Deletion of the VP1/2 Proline-Rich Sequences Impairs PRV Retrograde Axon Transport in Cultured Sensory Neurons
To analyze PRV retrograde intracellular transport, PRV encoding a fluorescent-capsid reporter (mRFP1-VP26 fusion) and either wild-type VP1/2 (WT), VP1/2 R6 S (MUT), or repaired VP1/2 (VP1/2 R6 S > WT VP1/2; REP) were isolated. Single-step growth of the MUT virus was initially delayed relative to the WT and REP viruses and plaque diameters were reduced, which was consistent with a trafficking defect ( Figures 4A and 4B) . Although VP1/2 is essential for virion assembly, there was no reduction in the incorporation of seven structural proteins in the MUT virus and only a statistically insignificant change in particle:plaque-forming unit (pfu) was measured ( Figure S3 ).
To determine the effect of the VP1/2 R6 S allele on retrograde axon transport, primary dorsal root ganglion (DRG) sensory neurons were infected with WT, REP,or MUT viruses, and capsid transport events were captured by time-lapse fluorescence imaging prior to 1 hr postinfection (hpi) ( Figure 5A ). WT and MUT viruses entered axons at equal frequency based on the measured flux of retrograde transport events in excess of 5 mm observed at the distal axons: WT = 0.70 ± 0.07 (moving particles/recording ± SD; n = 261); MUT = 0.67 ± 0.08 (moving particles/recording ± SD; n = 187). Transport dynamics were further surveyed mid-axon by measuring the lengths and average velocities of continuous retrograde transport events, termed runs. PRV lacking region 6 S maintained wild-type retrograde transport velocities, indicating that dynein recruitment to incoming capsids remained in tact ( Figures  5B and 5D) ; however, the MUT virus showed a small shift toward shorter runs (Figures 5C and 5E) . Moreover, capsids of the MUT virus displayed an increase in short-lived reversal events that were similar to those normally seen during wild-type infection at lower frequency. While these transient reversals did not manifest as sustained anterograde transport events, they contributed to the reduced efficiency of retrograde transport ( Figure  5F ).
The changes in retrograde transport dynamics exhibited by the MUT virus predicted that the proline-rich sequences of region 6 S contributed to the efficient delivery of capsids from axon terminals to the nucleus. If correct, the changes in retrograde transport dynamics should translate into a greater overall deficit when measured across the entire length of an axon. To test this prediction, an assay was developed to measure the efficiency of nuclear delivery following retrograde axon transport. DRG explants were coinfected at equal multiplicity with PRV encoding a capsid tagged with either a green or red fluorescent protein (GFPpUL25 or mCherry-pUL25), and images of sensory neurons within the explant were captured at 2-3 hpi to determine the proportion of green and red capsid accumulation at nuclear rims ( Figure 6A ). Neuronal soma embedded within intact ganglia are surrounded by support cells and are not expected to be directly exposed to viral inoculum, allowing for differences in retrograde axon transport to be detected. Because the accuracy of the assay required the strict adherence of equal multiplicity for the two reporter viruses, the viral stocks were individually titered prior to the study, and the titer of the combined inoculum used to infect the explants was subsequently reconfirmed. Neuron imaging experiments that were initiated with a combined inoculum in which the two viruses differed in titer by more than 2-fold were discarded from the final analysis. The WT virus accumulated at the nuclear membrane more effectively than the MUT virus ( Figure 6B ). This result was independent of which virus encoded the red or green fusion tag ( Figure 6C ). In contrast, coinfection of two WT viruses produced similar amounts of capsid accumulation at nuclear membranes ( Figure  6D ). In summary, changes in retrograde transport kinetics associated with the VP1/2 R6 S allele correlated with a defect in capsid delivery to neuronal nuclei. Based on these results, the phenotype associated with the VP1/ 2 R6 S allele was next examined in vivo.
Deletion of the VP1/2 Proline-Rich Sequences Impairs PRV Virulence and Retrograde Axon Transport In Vivo
The goal of the following studies was to determine the time of PRV transmission from a peripheral inoculation site to neuronal somas of the peripheral and central nervous system (PNS and CNS, respectively). Because PRV encoding a deletion equivalent to the VP1/2 R6 S allele was previously noted to exhibit reduced virulence in a mouse intranasal infection model, an equivalent study was first performed by inoculating the WT, MUT, and REP reporter viruses intranasally into mice and measuring mean survival times ( Figure 4C ) (Böttcher et al., 2007) . Mice infected with WT virus developed clinical symptoms 2 days postinfection (dpi) and died at an average time of 73 hpi. Similar results were obtained when mice were infected with REP virus. These results match those previously reported for PRV encoding fluorescent protein fusions to the VP26 capsid protein . Symptoms of infection were first noted inmice infected with MUT PRV at 5-6 dpi, with an average time to death of 139 hr (n = 4). One mouse infected with the MUT virus did not develop symptoms prior to the termination of the experiment at 3 weeks postinfection and was not included in the analysis. Thus, consistent with a previous report, deletion of VP1/2 region 6 S decreased virulence of PRV in a mouse model (Böttcher et al., 2007) . However, these data did not provide an indication if attenuation was due to a deficit in retrograde axon transport.
To focus specifically on the retrograde transport component of neuroinvasion, an established intraocular infection model was used (Pickard et al., 2002) . MUT or REP PRV encoding red capsids (mRFP1-VP26 fusion) were injected unilaterally into a rat eye anterior chamber ( Figure 7A ). Animals were sacrificed at varying times postinfection to examine the presence of virus fluorescence in the PNS and CNS. Intraocular smooth muscles of the iris and ciliary body receive sympathetic and parasympa-thetic innervation, and these autonomic circuits become infected after virus injection into the anterior chamber of the eye ( Figure 7A ) Pickard et al., 2002) . Invasion of the sympathetic retrograde circuit was monitored in the superior cervical ganglion (SCG) of the PNS and downstream in the paraventricular nucleus (PVN) of the CNS. The SCG consists of first-order neurons projecting axons to the iris; the PVN consists of third-order neurons that project axons to preganglionic spinal cord neurons of the intermediolateral nucleus (IML), which in turn project axons to the SCG. Invasion of the parasympathetic retrograde circuit was monitored in the Edinger-Westphal (EW) nucleus of the CNS, which consists of preganglionic secondorder neurons that project to the ciliary ganglion (CG) of the PNS, which in turn project to the iris and ciliary body ( Figure 7A ). The neuron populations included in the analysis were chosen based on the dependence on retrograde transport to produce infection and for ease of isolation and imaging. Infected neurons in the SCG, PVN, and EW were quantified by counting all cells expressing punctate intranuclear red fluorescence indicative of capsid assemblies (Desai et al., 1998; . In all instances, the MUT virus was delayed in invasion of retrograde circuitry relative to the REP virus ( Figures 7B-7D ). Neuroinvasion is a complex multifactorial phenotype, but nonetheless the in vivo results mimic those obtained in cultured DRG sensory explants and support the model that the proline-rich sequences in VP1/ 2 enhance retrograde axon transport by contributing to the recruitment of the dynactin complex to capsids, thereby promoting dissemination into the nervous system.
DISCUSSION
Upon entering cells many viruses engage microtubule motors to overcome the diffusion barrier of the cytoplasm (Luby-Phelps, 2000) . Surprisingly, these viral-host interactions often produce nondirected motion. In the case of adenovirus, capsids participate in minusend (retrograde) and plus-end (anterograde) directed motion at approximately equal frequency, resulting in random motions that collectively produce only small changes in net displacement (Gazzola et al., 2009; Suomalainen et al., 1999) . This dynamic indicates that facilitated diffusion is sufficient to produce favorable odds that an adenovirus capsid will arrive at its destination (i.e., a nuclear pore); targeted motion may notbe necessary for productive infection. For neuroinvasive viruses, facilitated diffusion alone cannot account for the trafficking of viral particles from axon nerve endings to neural soma that routinely occurs over the scale of centimeters. There has been very little insight garnered regarding how neuroinvasive herpesviruses, such as HSV and PRV, recruit the dynein microtubule motor and produce the highly directed and sustained retrograde motion that is observed in axons of infected neurons (Antinone and Smith, 2010; .
Dynein is the minus-end-directed microtubule motor that is responsible for processive retrograde transport of cytoplasmic cargoes in mammalian cells (reviewed in Vallee et al., 2004) . Consistent with this critical function, many viruses recruit dynein to presumably facilitate nuclear delivery (Bremner et al., 2009; Döhner et al., 2002 Döhner et al., , 2006 Suikkanen et al., 2003) . While the mechanism of dynein recruitment is not well understood for any virus, there is increasing evidence that nonenveloped viruses, including adenovirus and papilloma virus, undergo conformational changes upon entry that expose minor capsid proteins that can bind dynein (Florin et al., 2006; Schneider et al., 2011; Wodrich et al., 2010) . Whether the intrinsic activities of these proteins are responsible specifically for dynein-based transport during infection has proven difficult to determine, and evidence for alternative mechanisms of dynein recruitment are documented (Bremner et al., 2009 ).
Herpesvirus entry into cells by membrane fusion results in the deposition of the capsid entry complex into the cytosol. While several tegument proteins are dispensable for retrograde transport, the role of the VP1/2 tegument component of the entry complex has remained untested, as virions fail to assemble in the absence of the protein Desai, 2000; Fuchs et al., 2004) . HSV capsid-tegument complexes bind to dynein, kinesins, and dynactin in vitro, and mutations in VP1/2 interfere with capsid delivery to nuclear pores (Abaitua et al., 2012; Radtke et al., 2010; Schipke et al., 2012) . Together, these findings support a possible role for VP1/2 in microtubule transport.
The current study documents that VP1/2 is a microtubule transport effector based on the following evidence: (1) VP1/2 associates with constituents of dynein and dynactin and cosediments with dynein/dynactin complexes, (2) VP1/2 engages in rapid and processive microtubule transport in the absence of other viral proteins, and (3) VP1/2 moves large surrogate cargoes through the cytoplasm. Mutants of PRV were isolated to determine if these intrinsic activities contributed to retrograde transport during infection. Because transport following entry could not be studied with a knockout virus, mapping studies were instead used to identify regions of VP1/2 that contributed to the dynactin interaction. The dynactin complex enhances the processivity of the dynein motor and, interestingly, is recruited to capsid-tegument complexes independent of dynein (Kardon et al., 2009; King and Schroer, 2000; Radtke et al., 2010) . We hypothesized that dynactin may serve to sustain the longdistance retrograde capsid motion important for axon transport and that mutants with impaired dynactin binding may remain viable.
Although binding to dynactin proved to be complex, with multiple regions of VP1/2 contributing to the interaction, a large proline-rich sequence located in the C-terminal half of the protein was identified as one determinant. In agreement with a previous report, PRV carrying an in-frame deletion of the proline-rich region coding sequence (VP1/2 R6 S ) was viable, allowing for an assessment of VP1/2 function following entry into cells (Böttcher et al., 2006) . The VP1/2 R6 S mutant transported at wild-type retrograde velocity, but over shorter distances compared to PRV encoding wild-type VP1/2, consistent with dynactin serving to enhance the processivity of capsid motion. When cultured neurons were coinfected with PRV encoding either wild-type VP1/2 or VP1/2 R6 S , the wild-type viruses outran the mutants. This result provided an independent confirmation of the transport defect and further demonstrated that the defective instantaneous dynamics of capsid motion observed over short distances were amplified over the full length of the axon. In a final test, viruses encoding VP1/2 R6 S were slower at transporting in rat autonomic retrograde circuits. This decrease in neuroinvasion kinetics correlated with a decreased virulence in a mouse intranasal infection model that requires retrograde axon transport for neuroinvasion (Babic et al., 1994) . While it was not possible to ascribe causality of the retrograde kinetic defect observed in culture to the delay in neuroinvasion observed in vivo, the results were nevertheless consistent with a role for VP1/2 and dynactin recruitment in prolonged retrograde capsid transport in axons, neuroinvasion, and pathogenesis.
These studies provide insights into mechanisms underlying herpesvirus intracellular transport and neuroinvasion. In addition to these functions, the VP1/2 tegument protein is recognized for its critical roles in genome injection through nuclear pores and subsequently in the assembly and egress of progeny virions (Batterson et al., 1983; Desai, 2000) . The protein is regulated during both stages of infection by proteolytic processing (Jovasevic et al., 2008; . In contrast, the microtubule transport effector functions of VP1/2 were regulated by an interaction with the capsid protein, pUL25. Because removal of the pUL25 C-terminal binding site in VP1/2 resulted in constitutive and robust microtubule motion, we suggest that the C terminus maintains VP1/2 in an inactive confirmation that can be relieved by the pUL25 interaction. This model predicts that during infection newly translated VP1/2 would remain inactive until becoming capsid bound. How the proline-rich region enhances the dynactin interaction is not clear, but its predicted disordered structure may contribute to conformational changes, indirectly affecting dynactin recruitment (Böttcher et al., 2006) . In a similar vein, the proline-rich region of the cellular tau protein enhances binding of microtubules (Goode et al., 1997) . Alternatively, the disordered proline-rich sequence may recruit dynactin by mimicking a misfolded protein that normally would be moved to the MTOC by dynein/dynactin (reviewed in Wileman, 2007) . VP1/2 is also implicated in recruiting the kinesin motor to enveloped cytoplasmic viral particles late in infection (Shanda and Wilson, 2008) . Understanding how VP1/2 coordinates dynein and kinesin throughout infection will be of particular interest. VP1/2 is noted for its deubiquitinase activity resulting from a cysteine protease domain in the N terminus (Schlieker et al., 2005) . In PRV, mutation of the catalytic cysteine of the protease domain results in loss of neuroinvasion in vivo without perturbing viral replication in somatic tissues . Because the VP1/2 R6 S mutant of PRV presented to a lesser extent a neuroinvasive defect in the same in vivo infection model, the possibility that VP1/2 orchestrates a series of steps that contribute to neu-roinvasion seems reasonable. In summary, we document that VP1/2 is a herpesvirus effector of retrograde microtubule transport that enhances neuroinvasion by recruiting the dynactin complex.
EXPERIMENTAL PROCEDURES Cells and Virus Propagation
Vero (African green monkey kidney epithelial), HEK293 (human embryonic kidney), and PK15 (pig kidney epithelial) cells were grown in DMEM (Dulbec-co's modified Eagle's medium, Invitrogen) supplemented with 10% BGS (bovine growth supplement, HyClone); BGS levels were reduced to 2% during infection. All recombinant viruses were derived from the pBecker3 infectious clone of PRV-Becker. Infectious clones were transfected into PK15 cells as previously described . The resultant stock of virus was passaged once more to create a working stock. Titers of working stocks were obtained by plaque assay as previously described . Plaque sizes of mRFP1-VP26 encoding viruses were measured by live-cell fluorescence imaging. Vero cells in 6-well trays were infected at a concentration of 100-300 pfu per well. Cells were overlaid with methyl cellulose, and plaques were allowed to expand for 2-3 days. Images of at least 30 isolated plaques from each virus strain were acquired with a Nikon Eclipse TE2000-U inverted microscope and a 0.30 NA 103 objective. The average of two orthogonal diameter measurements was calculated for individual plaques and expressed as a percentage of the diameter of PRV-GS847, which was always tested in parallel. Values reported are an average of three independent experiments. Characterization of virus growth kinetics was previously described , and further details are provided in the Supplemental Experimental Procedures. Culturing DRG from embryonic chicken (E8) on polyornithine-and laminin-treated coverslips was previously described ). Ganglia were cultured in defined DMEM/F12 (Invitrogen, 11039-021) medium for 2 days before viral infection.
Viruses and Plasmids
Plasmids, primers, and cloning details are described in Supplemental Experimental Procedures. The viruses used in this study are listed in Table S1 . Primers and plasmids are listed in Tables S2 and S3 . Transfections were done using polyethylenimine (PEI, Polysciences, catalog no. 23966) or Lipo-fectamine 2000 (Invitrogen). For some experiments, cells were treated with 10 µ;M nocodazole or 0.5 µ;M cytochalasin D before imaging. Additional details are provided in Supplemental Experimental Procedures.
Coimmunoprecipitation and Western Blot Analysis
HEK293 cells transiently expressing GFP and GFP-tagged VP1/2 mutants were treated with 10 µ;M nocodazole (VWR) for 1 hr, washed once with cold PBS supplemented with 0.1 mM phenylmethylsulfonyl fluoride, and lysed 18-24 hr posttransfection in 500 µl/well of cold TAP lysis buffer supplemented with 10 µM nocodazole, 1 mM dithiothreitol, and phosphatase and protease inhibitors. Sepharose A/G beads were loaded with anti-GFP antibodies, washed three times with cold TAP lysis buffer, and incubated with precleared lysates overnight at 4°C. The beads were washed four times and resuspended in loading buffer. Samples were heated at 75°C for 20 min, separated on sodium dodecyl sulfatepolyacrylamide gel, and transferred to PVDF Hybond-P membranes (GE Healthcare). Membranes were blocked and incubated with primary antibody at 4°C overnight. Following incubation with a horseradish peroxidase-conjugated goat anti-mouse antibody (Jackson ImmunoResearch), the blots were processed for chemiluminescence and quantitated by densitometry. The efficiency of protein interaction was described as the ratio of coimmunoprecipitated protein to primary immuno-precipitated protein.
Microscopes and Imaging
Live-cell images were acquired with a Nikon Eclipse TE2000 inverted wide-field fluorescence microscope fitted with a 60 × 1.40 NA oil objective and either a Photometrics CoolSnap HQ2 or a Cascade 650 charge-coupled device (Photometrics, Roper Scientific). All microscopes were housed in a 37°C environmental box (In Vivo Scientific), and infected or transfected cells were imaged in VALAB (Vaseline, lanolin, and beeswax) sealed chambers as previously described . Mitochondria were stained with MitoTracker Red CMXRos (1:10,000; Invitrogen) according to the manufacturer's protocol.
Analysis of viral particle movement was described previously . To determine the efficiency of virus delivery to the nuclear rim, 2-day-old DRG explants were coinfected with two viruses. Because the accuracy of the assay readout required strict adherence of equal multiplicity for the reporter virus pairs, the viral stocks were titered both before and after infection of the explants. The stocks were thawed, sonicated, and centrifuged at 3003×g for 5 min at room temperature to eliminate cell debris. A mixed stock of the two viruses containing equivalent titers for each virus was prepared and used to infect the DRG. In addition to being used to infect the neurons, the working dilutions of individual prepared viruses were used to confirm the titers of each virus. Neuron imaging experiments that were subsequently determined to have been infected with mixed stocks in which the two viruses differed in titer by more than 2-fold were discarded from the final analysis. Static images from multiple infected neurons were captured 2-3 hr postinfection with sequential RFP and GFP exposures. The three infection pairs were coded and analyzed blindly to determine the most predominant virus color present at specific nuclear rims. Results are presented as the averages of > 5 experiments for each virus combination. The frequency of capsid retrograde transport events (flux) was measured in distal axons of DRG. Two sets of three DRG explants were cultured for 2 days and infected at equal moi with either wild-type or mutant virus (VP1/2 R6 S ). Each virus stock was thawed, sonicated, and centrifuged at 3003×g for 5 min at RTto eliminate cell debris before infection. Viral stocks were titered before and after the experiment as described above. Distal axons were imaged between 10 and 45 min postinfection. In total, 187 movies were recorded for the mutant virus and 261 movies were recorded for wild-type virus. Particle entry flux was determined as the number of moving particles per recording. In order to be scored, particles had to travel at least 5 µm. Additional details are provided in Supplemental Experimental Procedures.
Animal Studies
Animals (CD-1 mice and Long-Evans rats, males, Charles River Breeding Laboratories) were maintained under 12 hr light:12 hr dark conditions throughout with food and water continuously available. All procedures conformed to NIH guidelines for work with laboratory animals and were approved by the Institutional Animal Care and Use Committee of the University of Nebraska, Lincoln. Intranasal infection of CD-1 mice was previously described . Intraocular injections of male Long-Evans rats, isolation of nervous tissues, and processing for fluorescence imaging were previously described ). Further details of both protocols are provided in Supplemental Experimental Procedures.
Statistical Analysis
Statistical significance was determined by unpaired two-tailed Student's t test for pairwise comparisons. For comparison of multiple experimental groups to a control, a one-way analysis of variance (ANOVA) was performed with a post hoc Tukey's test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. (B) Anchoring of VP1/2 to the surface of mitochondria promoted organelle redistribution. GFP-VP1/2 R7 fused to a membrane targeting sequence that directs association with the outer surface of mitochondria (GFP-R7-MTS) or coexpression of mCherry-VP1/2 and pUL25-GFP-MTS fusions resulted in redistribution of mitochondria to the perinuclear region of Vero cells (yellow arrowheads). A GFP-MTS fusion served as a negative control and a GFP-BICD-N-MTS fusion as a positive control. Cells were stained with MitoTracker Red to visualize mitochondria. (C) Summary of mitochondria redistribution results. Values are the percentage of cells with clustered mitochondria ± standard error of the proportion (SEP). Asterisks indicate statistically significant difference from GFP-MTS (***p < 0.0001, **p < 0.001) as determined by Student's t test. All images (A-C) were captured between 18 and 24 hpt. Scale bars are 20 mm. See also Figure S1 and Movie S1. (D) Removal of regions 1-5 did not impair dynactin (p50/dynamitin and p150/glued) interaction with VP1/2 R7. (E) VP1/2 region 6 S was required for efficient interaction with dynactin. Mutation of the NLS (K 285 RRR > AAAA change) did not restore the interaction. (F) VP1/2 regions 6 and 7 were sufficient for dy-nactin interaction, but regions 1-4 were required for optimal binding. Densitometry plots show normalized p150/glued and p50/ dynamitin binding efficiencies. Values in bar graphs (A-F) are averages ± SD. Number of repetitions is indicated (n). Asterisks indicate statistically significant difference from fulllength VP1/2-GFP as determined by Student's t test (***p < 0.0001, **p < 0.001). For all experiments, HEK293 cells were lysed 16-18 hr posttransfection, and VP1/2 was immunoprecipitated with anti-GFP antibody. Coimmunoprecipitated endogenous proteins were detected by western blot. INP, input (6% of crude lysate). See also Figure S2 . Removal of region 6 resulted in VP1/2 localization to the nucleus by unmasking a cryptic nuclear localization signal (NLS) in region 2 of the protein, as previously described for HSV-1 VP1/2 (Abaitua and O'Hare, 2008) . Because GFP-VP1/2∆R6∆R7 and GFP-VP1/2∆R6 S ∆R7 displayed nuclear restricted fluorescence that may have accounted for the poor interaction with dynactin, versions of each truncation carrying a K 285 RRR>AAAA NLS mutation was produced and confirmed to localize in the cytoplasm of transfected Vero cells. Further analysis of these constructs is included in Figure 3E . Images were captured approximately 18 hpt. Scale bar, 20 µm.
(B) The VP1/2 fragment consisting of regions 6 and region 7 (VP1/2c-GFP) or GFP alone (GFP) were transiently expressed in HEK293 cells. Cleared cell lysates were sedimented through gradients of 10-40% sucrose and collected in twelve fractions. Following gel electrophoresis, samples were immunoblotted for GFP, DIC 74.1 (dynein component), and p150/glued (dynactin component). Results from two independent experiments are shown. Densitometry was analyzed in ImageJ and illustrated in line graphs below each blot. Crude cell lysate (Input) and pellets obtained after clearing the cell lysates were included for comparison, with the percentages indicating amount of each loaded on the gel. (C) GFP signal intensity in the peak dynein fraction (fraction #8). The GFP control had no signal in fraction #8 ( §). Table S2 . Primers used to introduce in-frame deletions and codon changes in the VP1/2 gene (UL36) of the pBecker3 infectious clone by two-step RED-mediated recombination, related to Experimental Procedures 
Supplemental Experimental Procedures
Cells and virus propagation. Vero (African green monkey kidney epithelial), HEK 293 (human embryonic kidney) and PK15 (pig kidney epithelial) cells were grown in DMEM (Dulbecco's Modified Eagle Medium, Invitrogen) supplemented with 10% BGS (bovine growth supplement, HyClone). BGS levels were reduced to 2% during infection. Primary dorsal root ganglia (DRG) from embryonic chicken (E8-E9) were cultured for 2 days on polyornithine and laminin treated coverslips as previously described .
Infectious clones of PRV-Becker were transfected into PK15 cells as previously described . The resultant stock of virus was passaged once more to create a working stock. Titers of working stocks were obtained by performing plaque assays on PK15 or Vero cells as previously described .
Viruses. All viruses used in this study were derived from the pBecker3 infectious clone and are listed in Table S1 (Smith et al., 2000) . Viruses encoding fluorescent capsid tags were previously described: PRV-GS847 , PRV-GS4379, and PRV-GS4284 . PRV-GS847 encodes a mRFP1-VP26 fusion, whereas PRV-GS4379 and PRV-GS4284 encode UL25 with a double inframe GFP or mCherry insertion, respectively. PRV-GS909 encodes mRFP1-VP26 and GFP-VP1/2 fusions, and was previously described .
The UL36 R6 S deletion (codons 2080-2796 of 3095 total) was introduced by two-step red-mediated recombination (Tischer et al., 2006) using primers indicated in Table S2 . Codon numbering was based on the PRV-Becker sequence; GenBank JF797219.1 . This resulted in pGS2111 (derived from pGS847) and pGS4400 (derived from pBecker3). The pGS2111 clone was further modified to encode GFP fused to the amino terminus of VP1/2, using primers: 5' AAAGATTTTTCCCCCACGCGCGTGTGTTATTTCAGCCATGGTGAGCAAGGGCGAG and 5' CATACTGATTACGATAGCCGACGACCACCGCGTCGGCCGTCTTGTACAGCTCGTC. The regions of homology with pEP-EGFP-in template are underlined. This resulted in pGS2175. The pGS4400 clone was further modified to encode a fluorescent capsid tag by inserting GFP or mCherry into UL25 as previously described . This resulted in pGS4444 and pGS4482, respectively.
To repair the UL36 R6 S deletion in pGS2111, three sequential recombination reactions were performed.
First, an I-SceI endonuclease site and kanamycin cassette (I-sceI/kan) was inserted into the R6 S region of UL36 using the following primers: 5' GGGCTCGGAGTCCGATGTCCCCGGAGGAGAGCGGGTCCGATGCTGGTCTGGTCCGACCGTC AACCAATTAACCAATTCTGATTAG and 5' AAAGCGGGGCGCGCAGACAAGTGCGAACACACGGTCGGACCAGACCAGCATCGGACCCGC AGGATGACGACGATAAGTAGGG. The regions of homology with pEPkan-S2 template are underlined. This resulted in pGS3909. Second, the I-sceI/kan cassette with UL36 flanking sequences that span beyond the R6 S deletion were recombined into a small R6K plasmid, pGS1292, as previously described . A linear fragment of pGS1292 was amplified using the primers 5'GAGCGTGAAGCCCGGGCGTCGCGGCGGCTCGGGCGGCGCCATAAGCTTGTCATCCATATC ACCACG (the HindIII restriction site is underlined) and 5'CTGGTGGACTCGCAGCTGGCGGTGTCGCGCGTGCTCTGGGATTTTTATCGAATTCCCACAT GTGGAATTCCCAT (the BsaBI site is underlined and EcoRI site is bold). The resulting PCR product was inserted into UL36 upstream of region 6 based on homologies in the 5' end of each primer, and the pGS1292 sequence and downstream UL36 fragment containing the I-sceI/kan insertion was liberated by BsaBI digestion and self-ligation between two BsaBI sites: one engineered in the primer and the other an endogenous site downstream of the UL36 ORF. The circularized plasmid was cloned into S17-1 λpir E. coli, resulting in pGS4005. Third, the UL36/I-sceI/kan fragment was isolated from pGS4005 by EcoRI and HindIII digestion and recombined into pGS2111 and the I-sceI/kan cassette was removed by two-step red-mediated recombination. The resulting recombinant was confirmed to encode a WT UL36 allele by sequencing, and saved as pGS4079. Transfection of pGS2111, pGS2175, pGS4079, pGS4444, pGS4482 into PK15 cells resulted in PRV-GS2111, PRV-GS2175, PRV-GS4079, PRV-GS4444 and PRV-GS4482, respectively.
Plasmids. Several VP1/2 expression plasmids were made as GFP fusions. All were derived from pBecker3 BACs that were modified to encode GFP fused in-frame to either the amino (pGS909) or carboxyl terminus of VP1/2 (pGS1903) . In addition, the VP1/2 ORF (UL36) was modified to encode in-frame deletions or a NLS mutation (KRRRR>AAAA) by two-step red-mediated recombination (Table S2 ). The UL36 alleles were subcloned from each BAC using a modified RED-GAM protocol as described previously . Briefly, a plasmid encoding a conditional R6K origin of replication and beta-lactamase (ampicillin resistance), pGS1292, was PCR amplified with primers that contained 5' homologies for targeted insertion into the pBecker3 derivatives into UL36. For BACs encoding GFP at the 5' end of UL36, pGS1292 was inserted at the 3' end of the desired region to be subcloned. For BACs encoding GFP at the 3' end of UL36, pGS1292 was inserted at the 5' end of the desired region to be subcloned. In either case, a BsrGI restriction site was included at the pGS1292 insertion. Using a corresponding BsrGI site within the GFP coding sequence, the UL36 fragment with the adjacent pGS1292 vector sequence was liberated by digestions with BsrGI and self ligated. The circularized plasmid was then cloned into S17-1 λpir E. coli, which allowed replication via the R6K origin. Finally, the cloned UL36 fragment was subcloned from the pGS1292 vector into either pEGFP-C1 or pEGFP-N1 (Clontech) to reconstitute the GFP coding sequence and establish the final expression plasmid (Table S3 ). Three additional VP1/2 expression plasmids were previously described:
, and GFP-[R1-R7] (pGS1521) .
A pUL25-GFP expression construct (pGS2099) was made using the same strategy as described above for the VP1/2 expression plasmids. The pBecker3 BAC was first modified by inserting the GFP coding sequence as an in-frame fusion to the 3' end of UL25, resulting in pGS1948. This was accomplished by two-step red-mediated recombination with primers: 5' TTTCTCTGCCTGGGCTATATCCCGCAGTTCGCCGCCGCCGTGAGCAAGGGCGAG and 5' CATGGCGGCGGCGGCGCGCGCGCGGAGACTGCGGGCTCACTTGTACAGCTCGTC (pEP-GFPin homology regions are underlined). The pGS1292 vector with a flanking BsrGI site was subsequently inserted immediately 5' of the UL25 ORF, and the pGS1292/UL25-GFP sequence was cloned by BsrGI digestion and self ligation, resulting in pGS2097. Finally, the cloned UL25 ORF was subcloned from pGS2097 into pEGFP-N1 (Clontech) to reconstitute the GFP coding sequence and establish the final expression plasmid: pGS2099.
GFP-MTS and GFP-BICD-N-MTS expression plasmids were a kind gift of Dr. Akhmanova . MTS is a membrane-targeting sequence of the C-terminus (last 26 codons) of the ActA protein of Listeria monocytogenes that is efficient at targeting proteins to the outer mitochondrial membrane (Bear et al., 2000; Bubeck et al., 1997) . GFP-BICD-N-MTS encodes the N-terminus (a.a. 1-594, out of 820) of Bicaudal D (BICD2) fused to GFP and MTS tags. To create fluorescent MTS-tagged PRV proteins, the MTS sequence was included in a primer sequence: 5'GGGGGATCCTTAATTATTTTTTCTTAATTGAATAATTTTGATAAACGCCCCTAAAGAGA ACACGCCAATAGCTAACATTGCAAGAATTAAGAATTCTTTGGACACGGCGTCGACCTCGG CCAGG (BamHI and EcoRI sites are underlined, MTS sequence is in bold, stop codon is italicized) and 5' GGGAAGCTTCGGAGGCGCTCGTGCGCGCGCTCGAGG (the HindIII site is underlined). The 3' end of each primer provided homology to the UL37 ORF. The resulting PCR product was subcloned by EcoR1 and HindIII double digestion into pEGFP-C1. The resulting expression plasmid, pGS1823, encodes a GFP-pUL37-MTS fusion. The UL36-MTS expression construct was made by replacing the UL37 sequence in pGS1823 with UL36 [R1-R6] using BsrGI and EcoRI combined digestion, resulting in pGS2636. To fuse UL25-GFP with the MTS tag, UL25-GFP was first subcloned from pGS2099 into pEGFP-C2 (Clontech) using BsrG1 and SnaBI combined digestion, followed by subcloning into pGS1823 using AseI and EcoRI. The resulting pUL25-GFP-MTS fusion expression plasmid was saved as pGS2500.
Viral propagation and cell-cell spread kinetics. Cell-associated virus and supernatants for single-step growth curves were harvested from PK15 cells at 2, 5, 8, 12, and 24 hours post removal of inoculum and processed as previously described . Titers of all time-points were quantified by plaque assay on Vero cells and plotted with GraphPad Prism 4.
Plaque sizes of mRFP1-VP26 encoding viruses were measured by live-cell fluorescence imaging. Vero cells in 6-well trays were infected at a concentration of 100-300 plaque forming units (PFU) per well. Cells were overlaid with 3 ml methocel media (DMEM supplemented with 2% BGS and 10 mg/ml methyl cellulose) and plaques were allowed to expand for two to three days. Images of at least 30 isolated plaques from each virus strain were acquired with a Nikon Eclipse TE2000-U inverted microscope with a 0.30 NA 10 X objective and RFP filter set. To determine the plaque diameter, the average of two orthogonal diameter measurements were calculated for each plaque using ImageJ software v. 1.42q (Abramoff et al., 2004) . Plaque diameters were expressed as a percentage of the diameter of PRV-GS847 which was always tested in parallel. There was no detectable difference in plaque diameters as a percentage of control plaque diameters between two and three days post infection. Values reported are an average of three independent experiments.
Virus retrograde transport kinetics. Analysis of viral particle movement was described previously . Briefly, two-day old DRG explants were infected with 7.0 x 10 6 PFU/coverslip of either WT, MUT or REP virus. Moving particles were detected by time-lapse fluorescence microscopy in the red fluorescence channel at 10 frames per second (100 ms exposures) during 30 second intervals. Particle velocities were determined using the kymograph function of the MetaMorph software package. Kymographs were generated using the "Multi-line" tool with a width of 20 pixels and "average background" subtraction. Entire particle paths, whether moving, stalled, or reversing, were traced within the kymograph using the "Multi-line" tool. Data was filtered post analysis to only include velocities of runs ≥ 0.5 µm. Histograms were made in GraphPad Prism 4, with bin sizes of 1 µm for run lengths and 0.4 µm/s for velocities. Built-in nonlinear regression analysis was used to fit Gaussian (velocity) or decaying exponential (run lengths) curves to the data. Three replicate experiments (n > 80 particles per experiment) were analyzed. P-values were determined by one-way analysis of variance and a post-hoc Tukey test.
To determine the efficiency of virus delivery to the nuclear rim, two-day old DRG explants were coinfected with two viruses at equal PFU (0.9-7.5 x 10 8 PFU/coverslip) in the following combinations:
PRV-GS4379 (GFP-WT) and PRV-GS4284 (RFP-WT); PRV-GS4379 (GFP-WT) and PRV-GS4482 (RFP-MUT); or PRV-GS4284 (RFP-WT) and PRV-GS4444 (GFP-MUT). Because the accuracy of the assay readout required strict adherence of equal multiplicity for the reporter virus pairs, the viral stocks were titered both before and after infection of the explants. Neurons were infected with viral stocks that had previously been titered. The stocks were thawed, sonicated, and centrifuged at 300 x g for 5 min at RT to eliminate cell debris. A mixed stock of the two viruses containing equivalent titers for each virus was prepared and used to infect the DRG. In addition to being used to infect the neurons, the working dilutions of individual prepared viruses were used to confirm the titers of each virus. Neuron imaging experiments that were subsequently determined to have been infected with mixed stocks in which the two viruses differed in titer by more than two fold were discarded from the final analysis. Static images from multiple infected neurons were captured 2-3 h post infection with 100 ms RFP and 500 ms GFP sequential exposures. The three infection pairs were coded and analyzed blindly to determine the most predominant virus color present at specific nuclear rims. Results are presented as the averages of ≥ 5 experiments for each virus combination.
The frequency of capsid retrograde transport events (flux) was measured in distal axons of DRG. Two sets of three DRG explants were cultured for two days and infected at equal MOI (5.4-5.8 x 10 6 PFU/coverslip) with either RFP-WT (PRV-GS847) or RFP-MUT (PRV-GS2111). Each virus stock was thawed, sonicated, and centrifuged at 300 x g for 5 min at RT to eliminate cell debris before infection. Viral stocks were titered before and after the experiment as described above. Distal axons were imaged between 10 and 45 min post infection using 100 ms exposures for 10 s (132 µm x 132 µm frame). In total, 187 movies were recorded for RFP-MUT and 261 movies were recorded for RFP-WT. Particle entry flux was determined as the number of moving particles per recording. In order to be scored, particles had to travel at least 5 µm.
Virion composition. Analysis of GFP-VP1/2 incorporation into individual extracellular virions was previously described . Briefly, PK15 cells were infected with PRV-GS909 or PRV-GS2175 at an MOI of 5 and incubated for 18 h. Supernatants were cleared of cell debris by centrifugation at 4800 x g for 10 min. Cleared supernatant (8 ml) was underlaid with a 1 ml cushion of 10% Nycodenz in PBS in an SW41 centrifuge tube. Samples were centrifuged at 38500 x g for 60 min. Pelleted virus was resuspended in 0.1 ml PBS, and 65 µl of a 1:50 dilution in PBS was spotted onto a plasma-cleaned microscope slide and imaged on a Nikon Eclipse TE2000 U wide-field fluorescence microscope fitted to a Cascade II camera (Roper Scientific) and a 100×1.49 numerical aperture (NA) objective. GFP was imaged using a 470/40 nm excitation filter and 525/50 nm emission filter; mRFP1 and mCherry were both imaged using a 572/35 nm excitation filter and 632/60 nm emission filter. To determine particle brightness, multiple fields of particles were captured with exposure times of 1.5 s. A custom algorithm for the MetaMorph software package (Molecular Devices) was used to quantify fluorescence intensity of individual extracellular virus particles.
